U.S. markets closed
  • S&P 500

    3,699.12
    +32.40 (+0.88%)
     
  • Dow 30

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,892.45
    +43.75 (+2.37%)
     
  • Crude Oil

    46.09
    +0.45 (+0.99%)
     
  • Gold

    1,842.00
    +0.90 (+0.05%)
     
  • Silver

    24.32
    +0.18 (+0.76%)
     
  • EUR/USD

    1.2127
    -0.0022 (-0.18%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • GBP/USD

    1.3438
    -0.0015 (-0.11%)
     
  • USD/JPY

    104.1400
    +0.2800 (+0.27%)
     
  • BTC-USD

    19,095.01
    +46.72 (+0.25%)
     
  • CMC Crypto 200

    365.19
    -14.05 (-3.71%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Kaskela Law LLC Announces Stockholder Investigation of Pandion Therapeutics, Inc. - PAND

·1 min read

PHILADELPHIA, PA / ACCESSWIRE / October 31, 2020 / Kaskela Law LLC, announces that it is investigating Pandion Therapeutics, Inc. ("Pandion") (NASDAQ:PAND) on behalf of the company's stockholders.

The investigation seeks to determine whether Pandion and/or the company's officers and directors have violated the securities laws or breached their fiduciary duties and whether Pandion investors have been harmed as a result of such actions.

Pandion stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 - 1585 or (888) 715 - 1740, or via email at skaskela@kaskelalaw.com, to discuss this investigation and their legal rights and options. Additional information may also be found at http://kaskelalaw.com/case/pandion-therapeutics-inc/.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC, please visit www.kaskelalaw.com.

CONTACT:
D. Seamus Kaskela, Esq.

KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
(888) 715 - 1740
skaskela@kaskelalaw.com
www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

SOURCE: Kaskela Law LLC



View source version on accesswire.com:
https://www.accesswire.com/613635/Kaskela-Law-LLC-Announces-Stockholder-Investigation-of-Pandion-Therapeutics-Inc--PAND